CNR1 and substance withdrawal syndrome: Using a combination of electrophysiology, pharmacology, molecular biology, and bioinformatics, the current study supports a novel hypothesis whereby M3 receptors, via Ca2+ mediated regulation of the cross-talk, stimulate CB1 promoter activity, which may be involved in the complex events leading to the development of addictive behaviors or withdrawal syndromes, or both.